Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YM150 vs Warfarin in Non-Valvular Atrial Fibrillation
NCT00448214Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of darexaban in Atrial fibrillation (AFib), sponsored by Astellas Pharma. Started Mar 2007; status: completed.
02
Drugs
darexaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00448214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00448214.